Skorpios Trust - Net Worth and Insider Trading
Skorpios Trust Net Worth
The estimated net worth of Skorpios Trust is at least $213 Million dollars as of 2025-05-02. Skorpios Trust is the of Akero Therapeutics Inc and owns about 3,271,829 shares of Akero Therapeutics Inc (AKRO) stock worth over $147 Million. Skorpios Trust is also the 10% Owner of Stoke Therapeutics Inc and owns about 6,906,181 shares of Stoke Therapeutics Inc (STOK) stock worth over $67 Million. Details can be seen in Skorpios Trust's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Skorpios Trust has not made any transactions after 2024-12-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Skorpios Trust
Skorpios Trust Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Skorpios Trust owns 2 companies in total, including Stoke Therapeutics Inc (STOK) , and Akero Therapeutics Inc (AKRO) .
Click here to see the complete history of Skorpios Trust’s form 4 insider trades.
Insider Ownership Summary of Skorpios Trust
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| STOK | Stoke Therapeutics Inc | 2024-12-23 | 10 percent owner |
| AKRO | Akero Therapeutics Inc | 2022-12-01 | other: Former 10% owner |
Skorpios Trust Latest Holdings Summary
Skorpios Trust currently owns a total of 2 stocks. Among these stocks, Skorpios Trust owns 3,271,829 shares of Akero Therapeutics Inc (AKRO) as of December 1, 2022, with a value of $147 Million and a weighting of 68.82%. Skorpios Trust also owns 6,906,181 shares of Stoke Therapeutics Inc (STOK) as of December 23, 2024, with a value of $67 Million and a weighting of 31.18%.
Latest Holdings of Skorpios Trust
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKRO | Akero Therapeutics Inc | 2022-12-01 | 3,271,829 | 44.87 | 146,806,967 |
| STOK | Stoke Therapeutics Inc | 2024-12-23 | 6,906,181 | 9.63 | 66,506,523 |
Holding Weightings of Skorpios Trust
Skorpios Trust Form 4 Trading Tracker
According to the SEC Form 4 filings, Skorpios Trust has made a total of 1 transactions in Akero Therapeutics Inc (AKRO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Akero Therapeutics Inc is the sale of 1,636,000 shares on December 1, 2022, which brought Skorpios Trust around $71 Million.
According to the SEC Form 4 filings, Skorpios Trust has made a total of 3 transactions in Stoke Therapeutics Inc (STOK) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Stoke Therapeutics Inc is the sale of 2,000,000 shares on December 23, 2024, which brought Skorpios Trust around $23 Million.
Insider Trading History of Skorpios Trust
- 1
Skorpios Trust Trading Performance
Skorpios Trust Ownership Network
Ownership Network List of Skorpios Trust
Ownership Network Relation of Skorpios Trust
Skorpios Trust Owned Company Details
What does Stoke Therapeutics Inc do?
Who are the key executives at Stoke Therapeutics Inc?
Skorpios Trust is the 10 percent owner of Stoke Therapeutics Inc. Other key executives at Stoke Therapeutics Inc include General Counsel & Corp Sec Jonathan Allan , director & CEO Kaye Edward M. Md , and Chief Medical Officer Barry Ticho .
Stoke Therapeutics Inc (STOK) Insider Trades Summary
Over the past 18 months, Skorpios Trust made 3 insider transaction in Stoke Therapeutics Inc (STOK) with a net sale of 7,537,500. Other recent insider transactions involving Stoke Therapeutics Inc (STOK) include a net sale of 137,864 shares made by Barry Ticho , a net sale of 43,647 shares made by Jonathan Allan , and a net sale of 85,745 shares made by Kaye Edward M. Md .
In summary, during the past 3 months, insiders sold 30,717 shares of Stoke Therapeutics Inc (STOK) in total and bought 0 shares, with a net sale of 30,717 shares. During the past 18 months, 7,865,488 shares of Stoke Therapeutics Inc (STOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 7,865,488 shares.
Stoke Therapeutics Inc (STOK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Stoke Therapeutics Inc Insider Transactions
Skorpios Trust Mailing Address
Above is the net worth, insider trading, and ownership report for Skorpios Trust. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Skorpios Trust's mailing address is: Limassol G4 3030.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
